# Treatment of Adult ALL With an MRD-directed Programme.

> **NCT00358072** · PHASE2 · COMPLETED · sponsor: **Northern Italy Leukemia Group** · enrollment: 280 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **BEHAVIORAL:** Postremission consolidation based on MRD status

## Key facts

- **NCT ID:** NCT00358072
- **Lead sponsor:** Northern Italy Leukemia Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2006-12
- **Final completion:** 2008-09
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2010-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358072, "Treatment of Adult ALL With an MRD-directed Programme.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00358072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*